VKTX Insider Trading Activity and SEC Form 4 Filings
VKTX insider trading summary
Over the past 12 months, insiders at Viking Therapeutics, Inc. (VKTX) reported 16 sales worth $18.3M by 4 insiders and 1 open-market purchase worth $150K by 1 insider on SEC Form 4. Net insider selling was $18.2M.
Latest VKTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Greg Zante | Chief Financial Officer | Sell | $710K (21,217 @ $33.47) |
| Jul 29, 2026 | Brian Lian | President & CEO | Sell | $4.9M (148,517 @ $33.32) |
| Jul 29, 2026 | Marianna Mancini | Chief Operating Officer | Sell | $610K (18,217 @ $33.47) |
| Mar 10, 2026 | Neil William Aubuchon | Chief Commercial Officer | Buy | $150K (4,475 @ $33.50) |
| Jan 5, 2026 | Brian Lian | President & CEO | Sell | $224K (6,400 @ $35.07) |
| Jan 5, 2026 | Brian Lian | President & CEO | Sell | $1.4M (41,276 @ $34.22) |
| Jan 5, 2026 | Brian Lian | President & CEO | Sell | $4.3M (132,454 @ $32.29) |
| Jan 5, 2026 | Brian Lian | President & CEO | Sell | $1.8M (53,279 @ $33.38) |
| Jan 5, 2026 | Marianna Mancini | Chief Operating Officer | Sell | $1.0M (31,961 @ $32.29) |
| Jan 5, 2026 | Marianna Mancini | Chief Operating Officer | Sell | $454K (13,600 @ $33.37) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.